Mitra Sorooshian, MD
Nephrology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 052514 · 552746 · 552756 · 752582 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sorooshian’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A51374 · Current
Licensed to practise in California · since 1992 · expires 2028-09-30 · University of London School of Medicine, University College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$323,623
Medicare paid this office $323,623 for 566 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 363 | $103,916 | $113 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 33 | $77,147 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $28,084 | $70 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $25,629 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $21,660 | $105 |
See all 13 services
| Return visit (30+ min) | 363 | $103,916 | $113 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 33 | $77,147 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $28,084 | $70 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $25,629 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $21,660 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $18,849 | $152 |
| New patient visit (60+ min) | 87 | $17,087 | $196 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $15,371 | $270 |
| New patient visit (45+ min) | 22 | $3,101 | $141 |
| Long return visit (40+ min) | 16 | $2,446 | $153 |
| Injection of drug or substance under skin or into muscle | 31 | $2,204 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $2,111 | $70 |
| Automated urinalysis test | 16 | $35 | $2 |
Who their Medicare patients are
566 Original Medicare patients in 2024. Average age 78 · Under 65 6% · 85 and older 25% · Women 56% · Also on Medicaid 19% · Health risk score 2.65. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 49% · Coronary heart disease 35% · Heart failure 32% · Atrial fibrillation 29% · Depression 21% · Cancer 17% · COPD 16% · Dementia 13% · Stroke 12%.
The office billed $1,567,466, Medicare allowed $422,228 and paid $323,623; for 35,403 services of 16 kinds; $77,147 of it was for drugs given in the office and $246,476 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 566 | 35,403 | 78 | 2.65 | $1,567,466 | $323,623 |
| 2023 | 558 | 20,758 | 77 | 2.80 | $1,273,801 | $298,271 |
| 2022 | 508 | 19,088 | 77 | 2.79 | $1,244,105 | $310,680 |
| 2021 | 556 | 16,737 | 77 | 2.89 | $1,200,002 | $316,116 |
| 2020 | 551 | 18,232 | 77 | 2.84 | $1,141,316 | $285,681 |
| 2019 | 640 | 15,006 | 77 | 2.68 | $1,042,615 | $284,946 |
| 2018 | 607 | 11,382 | 77 | 2.74 | $967,647 | $266,178 |
| 2017 | 607 | 14,814 | 78 | 2.75 | $1,040,183 | $295,652 |
| 2016 | 550 | 14,460 | 76 | 2.93 | $954,493 | $272,933 |
| 2015 | 493 | 14,259 | 77 | 3.06 | $942,881 | $283,530 |
| 2014 | 454 | 13,446 | 76 | 3.18 | $879,460 | $252,238 |
| 2013 | 401 | 15,382 | 76 | 3.11 | $851,746 | $237,959 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 335 | $93,501 | $113 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 23 | $43,592 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $34,638 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $26,977 | $73 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $25,479 | $274 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $23,870 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $22,113 | $109 |
| New patient visit (45+ min) | 76 | $10,774 | $142 |
| Short return visit (20+ min) | 36 | $5,015 | $81 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $1,975 | $66 |
| Injection of drug or substance under skin or into muscle | 23 | $1,453 | $14 |
2022: 11 services
| Return visit (30+ min) | 313 | $92,772 | $113 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19 | $41,478 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 39 | $39,223 | $189 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $31,676 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $29,699 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $21,460 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $20,603 | $182 |
| New patient visit (45+ min) | 63 | $9,470 | $150 |
| Short return visit (20+ min) | 48 | $5,468 | $84 |
| Injection of drug or substance under skin or into muscle | 19 | $1,441 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,370 | $49 |
2021: 12 services
| Return visit (30+ min) | 318 | $96,718 | $117 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $44,957 | $281 |
| Dialysis services, 1 physician visit per month (20 years or older) | 42 | $43,942 | $185 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22 | $38,118 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $23,202 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $22,935 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $10,840 | $95 |
| New patient visit (45+ min) | 70 | $10,570 | $151 |
| Long return visit (40+ min) | 35 | $6,179 | $177 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $3,695 | $58 |
| Short return visit (20+ min) | 34 | $2,671 | $67 |
| Injection of drug or substance under skin or into muscle | 21 | $1,258 | $14 |
2020: 14 services
| Return visit (30+ min) | 348 | $67,854 | $90 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 26 | $46,980 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 35 | $32,202 | $177 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $29,007 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $27,957 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $25,257 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $14,203 | $98 |
| Telephone medical discussion with physician, 11-20 minutes | 118 | $11,608 | $71 |
| Short return visit (20+ min) | 83 | $8,642 | $71 |
| New patient visit (45+ min) | 41 | $6,174 | $151 |
| Injection of drug or substance under skin or into muscle | 29 | $1,646 | $14 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,349 | $96 |
| Influenza vaccine split virus, preservative free | 11 | $671 | $61 |
| Administration of influenza virus vaccine | 11 | $230 | $21 |
2019: 12 services
| Return visit (30+ min) | 457 | $107,065 | $96 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22 | $36,986 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $27,217 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 120 | $25,341 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $20,450 | $181 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $19,133 | $222 |
| New patient visit (45+ min) | 132 | $18,165 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $12,691 | $95 |
| Long return visit (40+ min) | 12 | $1,766 | $136 |
| Injection of drug or substance under skin or into muscle | 22 | $1,688 | $16 |
| Short return visit (20+ min) | 15 | $1,143 | $60 |
| Manual urinalysis test with examination using microscope, non-automated | 19 | $75 | $4 |
2018: 10 services
| Return visit (30+ min) | 399 | $96,246 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $31,116 | $65 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14 | $25,799 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $25,520 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $22,980 | $181 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $20,211 | $217 |
| New patient visit (45+ min) | 114 | $15,376 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $13,856 | $94 |
| Injection of drug or substance under skin or into muscle | 15 | $1,812 | $20 |
| Manual urinalysis test with examination using microscope, non-automated | 29 | $112 | $4 |
2017: 13 services
| Return visit (30+ min) | 377 | $91,404 | $92 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22 | $33,489 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $32,843 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $27,317 | $181 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $22,931 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $21,687 | $93 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $21,492 | $163 |
| New patient visit (45+ min) | 133 | $19,391 | $146 |
| Dialysis services, per day, less than full month service (20 years or older) | 18 | $5,880 | $7 |
| Injection of drug or substance under skin or into muscle | 23 | $3,022 | $26 |
| Short return visit (20+ min) | 19 | $1,614 | $65 |
| New patient visit (30+ min) | 14 | $1,138 | $81 |
| Manual urinalysis test with examination using microscope, non-automated | 23 | $98 | $4 |
2016: 12 services
| Return visit (30+ min) | 325 | $79,829 | $93 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 21 | $36,047 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 140 | $31,217 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $23,812 | $64 |
| Dialysis services, 1 physician visit per month (20 years or older) | 32 | $23,419 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $21,907 | $175 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $21,651 | $212 |
| New patient visit (45+ min) | 111 | $16,455 | $148 |
| Injection of drug or substance under skin or into muscle | 23 | $3,244 | $25 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $2,852 | $7 |
| New patient visit (30+ min) | 14 | $1,410 | $101 |
| Short return visit (20+ min) | 15 | $1,275 | $67 |
2015: 11 services
| Return visit (30+ min) | 284 | $70,644 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 130 | $37,555 | $97 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 18 | $34,917 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $29,850 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 112 | $25,202 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $24,500 | $187 |
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $22,442 | $173 |
| New patient visit (45+ min) | 100 | $14,996 | $150 |
| Dialysis services, per day, less than full month service (20 years or older) | 21 | $5,322 | $7 |
| Injection of drug or substance under skin or into muscle | 25 | $4,781 | $26 |
| Short return visit (20+ min) | 22 | $1,458 | $61 |
2014: 14 services
| Return visit (30+ min) | 238 | $63,524 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $38,081 | $92 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 26 | $29,886 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $26,187 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $20,349 | $64 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $18,697 | $212 |
| Dialysis services, 1 physician visit per month (20 years or older) | 29 | $18,536 | $166 |
| New patient visit (45+ min) | 77 | $11,149 | $145 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $6,002 | $250 |
| Dialysis services, per day, less than full month service (20 years or older) | 22 | $5,870 | $7 |
| Injection of drug or substance under skin or into muscle | 28 | $3,660 | $25 |
| Short return visit (20+ min) | 30 | $2,164 | $66 |
| Administration of influenza virus vaccine | 20 | $608 | $30 |
| Influenza vaccine split virus, preservative free | 14 | $458 | $33 |
2013: 11 services
| Return visit (30+ min) | 225 | $64,945 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 137 | $36,935 | $90 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 26 | $33,863 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $20,456 | $209 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $19,150 | $174 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $18,395 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $11,858 | $62 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $8,345 | $253 |
| New patient visit (45+ min) | 46 | $6,898 | $150 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $4,222 | $7 |
| Injection of drug or substance under skin or into muscle | 27 | $4,054 | $26 |
Medicaid work
$1,364 in 2024
Medicaid paid $1,364 for 127 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 127 | $1,364 |
| 2024 | 127 | 1 | 19 | $1,364 |
| 2023 | 245 | 3 | 22 | $5,802 |
| 2022 | 127 | 1 | 18 | $2,243 |
| 2021 | 77 | 1 | 18 | $1,053 |
| 2020 | 80 | 1 | 26 | $3,975 |
| 2019 | 149 | 1 | 21 | $4,433 |
| 2018 | 33 | 1 | 19 | $1,865 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 191 | $3,756 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $1,074 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $972 |
2022
| Return visit (30+ min) | 127 | $2,243 |
2021
| Return visit (30+ min) | 77 | $1,053 |
2020
| Return visit (30+ min) | 80 | $3,975 |
2019
| Return visit (30+ min) | 149 | $4,433 |
2018
| Return visit (30+ min) | 33 | $1,865 |
Drugs they prescribed that Part D paid
$417,687
Pharmacies billed $417,687 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (27 of 3,866) in 2024. Above the middle of the specialty; the typical nephrology clinician is at 0%.
3,523 generic and 330 brand-name prescriptions · $417,687 in drug cost · 92 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 85 | $91,171 | $1,073 |
| Farxiga | 64 | $61,324 | $958 |
| Ozempic | 30 | $28,852 | $962 |
| Kerendia | 18 | $19,511 | $1,084 |
| Sevelamer Carbonate | 70 | $14,777 | $211 |
See all 56 drugs
| Jardiance | 85 | $91,171 | $1,073 |
| Farxiga | 64 | $61,324 | $958 |
| Ozempic | 30 | $28,852 | $962 |
| Kerendia | 18 | $19,511 | $1,084 |
| Sevelamer Carbonate | 70 | $14,777 | $211 |
| Veltassa | 13 | $13,056 | $1,004 |
| Calcitriol | 429 | $6,956 | $16 |
| Calcium Acetate | 48 | $3,524 | $73 |
| Potassium Chloride | 52 | $3,259 | $63 |
| Tacrolimus | 12 | $3,238 | $270 |
| Losartan | 281 | $3,121 | $11 |
| Mycophenolate Mofetil | 11 | $3,028 | $275 |
| Amlodipine Besylate | 320 | $2,827 | $9 |
| Eplerenone | 51 | $2,795 | $55 |
| Nifedipine Er | 40 | $2,569 | $64 |
| Doxazosin Mesylate | 107 | $2,435 | $23 |
| Atovaquone | 12 | $2,168 | $181 |
| Furosemide | 273 | $2,149 | $8 |
| Potassium Citrate Er | 30 | $2,085 | $69 |
| Lisinopril | 177 | $1,676 | $9 |
| Hydralazine | 119 | $1,496 | $13 |
| Metoprolol | 116 | $1,481 | $13 |
| Midodrine | 22 | $1,296 | $59 |
| Allopurinol | 116 | $1,043 | $9 |
| Clonidine | 77 | $1,002 | $13 |
| Gabapentin | 49 | $990 | $20 |
| Pantoprazole | 43 | $937 | $22 |
| Benazepril | 45 | $852 | $19 |
| Atorvastatin | 93 | $818 | $9 |
| Spironolactone | 51 | $719 | $14 |
| Carvedilol | 54 | $531 | $10 |
| Hydrochlorothiazide | 70 | $408 | $6 |
| Tamsulosin | 30 | $335 | $11 |
| Valsartan | 19 | $332 | $17 |
| Omeprazole | 24 | $323 | $13 |
| Ondansetron | 23 | $318 | $14 |
| Minoxidil | 12 | $300 | $25 |
| Nitrofurantoin Mono-Macro | 15 | $272 | $18 |
| Torsemide | 12 | $262 | $22 |
| Sertraline | 21 | $254 | $12 |
| Simvastatin | 28 | $233 | $8 |
| Prednisone | 49 | $227 | $5 |
| Atenolol | 24 | $211 | $9 |
| Olmesartan Medoxomil | 12 | $209 | $17 |
| Hydroxyzine | 14 | $198 | $14 |
| Cephalexin | 37 | $183 | $5 |
| Metformin | 15 | $170 | $11 |
| Metoprolol | 26 | $164 | $6 |
| Losartan-Hydrochlorothiazide | 22 | $139 | $6 |
| Trazodone | 23 | $120 | $5 |
| Pravastatin | 14 | $118 | $8 |
| Tramadol | 13 | $117 | $9 |
| Lactulose | 12 | $93 | $8 |
| Cyclobenzaprine | 13 | $57 | $4 |
| Hydrocodone-Acetaminophen | 14 | $56 | $4 |
| Amoxicillin | 11 | $33 | $3 |
Year by year
| 2024 | 3,866 | 471 | 1% (27) | 9% | $417,687 |
| 2023 | 3,613 | 464 | 1% (19) | None | $393,333 |
| 2022 | 3,655 | 453 | 1% (31) | None | $302,608 |
| 2021 | 3,455 | 424 | 1% (38) | None | $251,875 |
| 2020 | 3,252 | 409 | 1% (21) | 10% | $205,990 |
| 2019 | 3,300 | 450 | 1% (46) | None | $191,413 |
| 2018 | 3,243 | 397 | 2% (55) | None | $220,779 |
| 2017 | 3,224 | 371 | 2% (66) | 15% | $397,013 |
| 2016 | 3,241 | 319 | 2% (55) | None | $370,388 |
| 2015 | 2,709 | 278 | 2% (60) | 15% | $284,305 |
| 2014 | 2,878 | 266 | 3% (86) | None | $272,544 |
| 2013 | 2,771 | 253 | 3% (74) | None | $247,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 52 drugs
| Jardiance | 65 | $77,841 | $1,198 |
| Farxiga | 64 | $54,464 | $851 |
| Sevelamer Carbonate | 83 | $35,846 | $432 |
| Veltassa | 13 | $12,691 | $976 |
| Calcitriol | 405 | $9,076 | $22 |
| Amlodipine Besylate | 342 | $4,546 | $13 |
| Losartan | 267 | $4,350 | $16 |
| Metoprolol | 124 | $2,518 | $20 |
| Lisinopril | 157 | $2,421 | $15 |
| Hydralazine | 118 | $2,338 | $20 |
| Calcium Acetate | 38 | $2,175 | $57 |
| Furosemide | 234 | $2,139 | $9 |
| Clonidine | 12 | $2,037 | $170 |
| Doxazosin Mesylate | 105 | $1,980 | $19 |
| Febuxostat | 18 | $1,917 | $107 |
| Atorvastatin | 95 | $1,669 | $18 |
| Midodrine | 12 | $1,666 | $139 |
| Allopurinol | 105 | $1,497 | $14 |
| Clonidine | 100 | $1,241 | $12 |
| Tamsulosin | 29 | $1,127 | $39 |
| Benazepril | 43 | $1,077 | $25 |
| Potassium Citrate Er | 13 | $1,009 | $78 |
| Potassium Chloride | 38 | $865 | $23 |
| Bumetanide | 11 | $850 | $77 |
| Nifedipine Er | 23 | $812 | $35 |
| Valsartan | 19 | $708 | $37 |
| Hydrochlorothiazide | 99 | $692 | $7 |
| Spironolactone | 61 | $678 | $11 |
| Olmesartan Medoxomil | 11 | $672 | $61 |
| Simvastatin | 30 | $614 | $20 |
| Carvedilol | 42 | $557 | $13 |
| Metoprolol | 33 | $546 | $17 |
| Omeprazole | 31 | $537 | $17 |
| Losartan-Hydrochlorothiazide | 22 | $508 | $23 |
| Ramipril | 12 | $501 | $42 |
| Atenolol | 29 | $477 | $16 |
| Azathioprine | 15 | $468 | $31 |
| Gabapentin | 31 | $427 | $14 |
| Torsemide | 12 | $416 | $35 |
| Sulfamethoxazole-Trimethoprim | 18 | $321 | $18 |
| Famotidine | 14 | $304 | $22 |
| Cephalexin | 35 | $275 | $8 |
| Pantoprazole | 13 | $256 | $20 |
| Hydroxyzine | 13 | $243 | $19 |
| Labetalol | 13 | $239 | $18 |
| Minoxidil | 11 | $210 | $19 |
| Oxcarbazepine | 15 | $184 | $12 |
| Sertraline | 16 | $91 | $6 |
| Prednisone | 15 | $84 | $6 |
| Trazodone | 20 | $70 | $3 |
| Cyclobenzaprine | 16 | $68 | $4 |
| Tramadol | 16 | $67 | $4 |
2022: 55 drugs
| Renvela | 15 | $64,194 | $4,280 |
| Sevelamer Carbonate | 92 | $35,192 | $383 |
| Jardiance | 29 | $32,267 | $1,113 |
| Veltassa | 12 | $11,360 | $947 |
| Calcitriol | 457 | $10,443 | $23 |
| Demeclocycline | 16 | $9,719 | $607 |
| Combivent Respimat | 12 | $5,338 | $445 |
| Losartan | 270 | $3,953 | $15 |
| Nifedipine Er | 40 | $3,934 | $98 |
| Amlodipine Besylate | 318 | $3,807 | $12 |
| Novolog | 12 | $3,613 | $301 |
| Calcium Acetate | 43 | $3,136 | $73 |
| Clonidine | 13 | $2,833 | $218 |
| Hydralazine | 122 | $2,824 | $23 |
| Mycophenolate Mofetil | 13 | $2,554 | $196 |
| Metoprolol | 97 | $2,547 | $26 |
| Doxazosin Mesylate | 134 | $2,498 | $19 |
| Furosemide | 237 | $2,281 | $10 |
| Lisinopril | 154 | $1,972 | $13 |
| Midodrine | 16 | $1,940 | $121 |
| Allopurinol | 98 | $1,881 | $19 |
| Clonidine | 111 | $1,685 | $15 |
| Prosol | 11 | $1,637 | $149 |
| Potassium Chloride | 33 | $1,626 | $49 |
| Gabapentin | 41 | $1,447 | $35 |
| Atorvastatin | 89 | $1,402 | $16 |
| Benazepril | 52 | $1,291 | $25 |
| Potassium Citrate Er | 13 | $1,235 | $95 |
| Tamsulosin | 48 | $1,229 | $26 |
| Spironolactone | 54 | $916 | $17 |
| Valsartan | 22 | $799 | $36 |
| Losartan-Hydrochlorothiazide | 26 | $764 | $29 |
| Colchicine | 18 | $751 | $42 |
| Nitrofurantoin Mono-Macro | 11 | $696 | $63 |
| Hydrochlorothiazide | 114 | $659 | $6 |
| Carvedilol | 39 | $619 | $16 |
| Omeprazole | 25 | $618 | $25 |
| Olmesartan Medoxomil | 12 | $597 | $50 |
| Simvastatin | 34 | $490 | $14 |
| Azathioprine | 14 | $467 | $33 |
| Metoprolol | 47 | $405 | $9 |
| Tramadol | 24 | $313 | $13 |
| Ramipril | 14 | $295 | $21 |
| Sulfamethoxazole-Trimethoprim | 18 | $268 | $15 |
| Pantoprazole | 17 | $263 | $15 |
| Famotidine | 14 | $230 | $16 |
| Glipizide Er | 11 | $224 | $20 |
| Prednisone | 20 | $188 | $9 |
| Zolpidem | 17 | $155 | $9 |
| Cephalexin | 23 | $114 | $5 |
| Atenolol | 16 | $102 | $6 |
| Trazodone | 11 | $93 | $8 |
| Sertraline | 15 | $85 | $6 |
| Cyclobenzaprine | 12 | $67 | $6 |
| Amoxicillin | 12 | $62 | $5 |
2021: 52 drugs
| Renvela | 19 | $55,418 | $2,917 |
| Sevelamer Carbonate | 92 | $27,320 | $297 |
| Calcitriol | 469 | $13,257 | $28 |
| Veltassa | 13 | $12,876 | $990 |
| Jardiance | 13 | $12,150 | $935 |
| Clinisol | 30 | $5,997 | $200 |
| Mycophenolate Mofetil | 20 | $5,309 | $265 |
| Nifedipine Er | 45 | $4,650 | $103 |
| Losartan | 220 | $3,568 | $16 |
| Amlodipine Besylate | 329 | $3,370 | $10 |
| Calcium Acetate | 37 | $2,891 | $78 |
| Potassium Citrate Er | 11 | $2,567 | $233 |
| Hydralazine | 118 | $2,366 | $20 |
| Furosemide | 222 | $2,363 | $11 |
| Metoprolol | 68 | $2,082 | $31 |
| Clonidine | 116 | $2,042 | $18 |
| Metolazone | 22 | $1,929 | $88 |
| Lisinopril | 164 | $1,797 | $11 |
| Doxazosin Mesylate | 67 | $1,675 | $25 |
| Valsartan | 16 | $1,640 | $102 |
| Allopurinol | 73 | $1,364 | $19 |
| Potassium Chloride | 27 | $1,259 | $47 |
| Benazepril | 56 | $1,203 | $21 |
| Midodrine | 32 | $1,137 | $36 |
| Atorvastatin | 80 | $1,016 | $13 |
| Tamsulosin | 35 | $976 | $28 |
| Losartan-Hydrochlorothiazide | 36 | $974 | $27 |
| Gabapentin | 46 | $919 | $20 |
| Colchicine | 16 | $869 | $54 |
| Carvedilol | 38 | $616 | $16 |
| Omeprazole | 28 | $606 | $22 |
| Lidocaine-Prilocaine | 17 | $581 | $34 |
| Azathioprine | 19 | $543 | $29 |
| Spironolactone | 33 | $504 | $15 |
| Hydrochlorothiazide | 79 | $476 | $6 |
| Glipizide Er | 19 | $395 | $21 |
| Simvastatin | 36 | $372 | $10 |
| Olmesartan Medoxomil | 13 | $356 | $27 |
| Sertraline | 22 | $342 | $16 |
| Nitrofurantoin Mono-Macro | 12 | $318 | $26 |
| Metoprolol | 56 | $308 | $5 |
| Prednisone | 31 | $305 | $10 |
| Ramipril | 14 | $224 | $16 |
| Cephalexin | 28 | $184 | $7 |
| Tramadol | 32 | $179 | $6 |
| Lactulose | 11 | $167 | $15 |
| Sulfamethoxazole-Trimethoprim | 13 | $157 | $12 |
| Atenolol | 15 | $115 | $8 |
| Cyclobenzaprine | 17 | $115 | $7 |
| Zolpidem | 12 | $97 | $8 |
| Trazodone | 19 | $94 | $5 |
| Amoxicillin | 11 | $31 | $3 |
2020: 49 drugs
| Renvela | 26 | $48,720 | $1,874 |
| Veltassa | 20 | $17,551 | $878 |
| Calcitriol | 489 | $13,991 | $29 |
| Sevelamer Carbonate | 35 | $9,743 | $278 |
| Tacrolimus | 13 | $6,397 | $492 |
| Losartan | 202 | $3,359 | $17 |
| Potassium Citrate Er | 25 | $3,205 | $128 |
| Nifedipine Er | 47 | $2,896 | $62 |
| Amlodipine Besylate | 326 | $2,761 | $8 |
| Mycophenolate Mofetil | 18 | $2,419 | $134 |
| Calcium Acetate | 32 | $2,370 | $74 |
| Clonidine | 135 | $2,306 | $17 |
| Valsartan | 20 | $2,032 | $102 |
| Doxazosin Mesylate | 60 | $2,016 | $34 |
| Colchicine | 12 | $1,889 | $157 |
| Furosemide | 202 | $1,862 | $9 |
| Metoprolol | 59 | $1,716 | $29 |
| Potassium Chloride | 33 | $1,700 | $52 |
| Hydralazine | 71 | $1,698 | $24 |
| Lisinopril | 171 | $1,634 | $10 |
| Allopurinol | 61 | $1,563 | $26 |
| Metolazone | 22 | $1,536 | $70 |
| Losartan-Hydrochlorothiazide | 21 | $1,235 | $59 |
| Atorvastatin | 70 | $1,082 | $15 |
| Midodrine | 15 | $934 | $62 |
| Hydrochlorothiazide | 96 | $890 | $9 |
| Azathioprine | 16 | $856 | $54 |
| Omeprazole | 38 | $790 | $21 |
| Benazepril | 45 | $719 | $16 |
| Glipizide Er | 31 | $716 | $23 |
| Lidocaine-Prilocaine | 14 | $702 | $50 |
| Tamsulosin | 31 | $553 | $18 |
| Olmesartan Medoxomil | 13 | $531 | $41 |
| Gabapentin | 23 | $499 | $22 |
| Spironolactone | 49 | $476 | $10 |
| Carvedilol | 41 | $427 | $10 |
| Simvastatin | 43 | $363 | $8 |
| Prednisone | 35 | $355 | $10 |
| Levothyroxine | 17 | $229 | $13 |
| Metoprolol | 44 | $226 | $5 |
| Atenolol | 28 | $223 | $8 |
| Famotidine | 17 | $214 | $13 |
| Enalapril Maleate | 11 | $213 | $19 |
| Sertraline | 11 | $198 | $18 |
| Cyclobenzaprine | 13 | $103 | $8 |
| Cephalexin | 21 | $100 | $5 |
| Trazodone | 11 | $90 | $8 |
| Tramadol | 14 | $90 | $6 |
| Glipizide | 12 | $67 | $6 |
2019: 56 drugs
| Renvela | 21 | $29,964 | $1,427 |
| Auryxia | 12 | $23,443 | $1,954 |
| Veltassa | 21 | $21,184 | $1,009 |
| Calcitriol | 485 | $13,676 | $28 |
| Sevelamer Carbonate | 25 | $8,889 | $356 |
| Doxazosin Mesylate | 84 | $3,447 | $41 |
| Nifedipine Er | 44 | $3,308 | $75 |
| Losartan | 185 | $3,148 | $17 |
| Tacrolimus | 11 | $2,999 | $273 |
| Amlodipine Besylate | 295 | $2,835 | $10 |
| Furosemide | 287 | $2,703 | $9 |
| Metoprolol | 67 | $2,283 | $34 |
| Clonidine | 148 | $2,254 | $15 |
| Potassium Chloride | 44 | $2,046 | $47 |
| Potassium Citrate Er | 12 | $1,991 | $166 |
| Lisinopril | 151 | $1,789 | $12 |
| Calcium Acetate | 18 | $1,741 | $97 |
| Allopurinol | 54 | $1,637 | $30 |
| Hydralazine | 67 | $1,285 | $19 |
| Atorvastatin | 59 | $1,173 | $20 |
| Lidocaine-Prilocaine | 27 | $1,081 | $40 |
| Valsartan | 24 | $1,065 | $44 |
| Benazepril | 53 | $1,064 | $20 |
| Mycophenolate Mofetil | 17 | $1,060 | $62 |
| Tamsulosin | 30 | $930 | $31 |
| Omeprazole | 28 | $890 | $32 |
| Azathioprine | 11 | $809 | $74 |
| Hydrochlorothiazide | 84 | $749 | $9 |
| Atenolol | 37 | $736 | $20 |
| Olmesartan Medoxomil | 11 | $658 | $60 |
| Mirtazapine | 16 | $630 | $39 |
| Spironolactone | 34 | $627 | $18 |
| Pantoprazole | 21 | $526 | $25 |
| Hydrocodone-Acetaminophen | 19 | $465 | $24 |
| Enalapril Maleate | 13 | $464 | $36 |
| Levothyroxine | 23 | $445 | $19 |
| Glipizide Er | 18 | $444 | $25 |
| Midodrine | 11 | $434 | $39 |
| Simvastatin | 53 | $431 | $8 |
| Ranitidine | 24 | $309 | $13 |
| Prednisone | 25 | $270 | $11 |
| Carvedilol | 26 | $265 | $10 |
| Losartan-Hydrochlorothiazide | 16 | $245 | $15 |
| Sertraline | 17 | $225 | $13 |
| Tramadol | 25 | $189 | $8 |
| Gabapentin | 15 | $181 | $12 |
| Metoprolol | 37 | $169 | $5 |
| Trazodone | 14 | $143 | $10 |
| Famotidine | 16 | $132 | $8 |
| Clopidogrel | 14 | $132 | $9 |
| Hydrocortisone | 15 | $126 | $8 |
| Cephalexin | 18 | $125 | $7 |
| Zolpidem | 11 | $125 | $11 |
| Ropinirole | 16 | $116 | $7 |
| Ramipril | 11 | $115 | $10 |
| Glipizide | 11 | $78 | $7 |
2018: 53 drugs
| Renvela | 42 | $54,900 | $1,307 |
| Veltassa | 26 | $27,210 | $1,047 |
| Sevelamer Carbonate | 20 | $21,518 | $1,076 |
| Calcitriol | 462 | $12,181 | $26 |
| Mycophenolate Mofetil | 18 | $4,098 | $228 |
| Demeclocycline | 11 | $3,731 | $339 |
| Doxazosin Mesylate | 81 | $3,063 | $38 |
| Nifedipine Er | 40 | $2,499 | $62 |
| Metoprolol | 72 | $2,214 | $31 |
| Losartan | 159 | $2,165 | $14 |
| Amlodipine Besylate | 233 | $2,018 | $9 |
| Furosemide | 262 | $1,913 | $7 |
| Clonidine | 160 | $1,902 | $12 |
| Lisinopril | 172 | $1,861 | $11 |
| Allopurinol | 69 | $1,800 | $26 |
| Midodrine | 28 | $1,709 | $61 |
| Atorvastatin | 66 | $1,492 | $23 |
| Potassium Chloride | 31 | $1,409 | $45 |
| Tamsulosin | 27 | $1,223 | $45 |
| Calcium Acetate | 25 | $1,087 | $43 |
| Valsartan | 24 | $1,051 | $44 |
| Benazepril | 61 | $859 | $14 |
| Omeprazole | 34 | $703 | $21 |
| Isosorbide Mononitrate Er | 14 | $687 | $49 |
| Hydralazine | 38 | $646 | $17 |
| Levothyroxine | 32 | $640 | $20 |
| Atenolol | 44 | $627 | $14 |
| Enalapril Maleate | 13 | $599 | $46 |
| Hydrochlorothiazide | 83 | $582 | $7 |
| Hydrocodone-Acetaminophen | 23 | $532 | $23 |
| Mirtazapine | 15 | $445 | $30 |
| Lidocaine-Prilocaine | 14 | $429 | $31 |
| Oxybutynin Chloride Er | 15 | $426 | $28 |
| Glipizide Er | 16 | $329 | $21 |
| Spironolactone | 17 | $323 | $19 |
| Ranitidine | 22 | $310 | $14 |
| Simvastatin | 64 | $269 | $4 |
| Sertraline | 21 | $266 | $13 |
| Gabapentin | 24 | $261 | $11 |
| Minoxidil | 12 | $252 | $21 |
| Losartan-Hydrochlorothiazide | 21 | $250 | $12 |
| Pantoprazole | 15 | $241 | $16 |
| Prednisone | 26 | $236 | $9 |
| Metoprolol | 26 | $231 | $9 |
| Carvedilol | 34 | $220 | $6 |
| Megestrol Acetate | 14 | $174 | $12 |
| Tramadol | 23 | $162 | $7 |
| Zolpidem | 14 | $143 | $10 |
| Hydrocortisone | 18 | $130 | $7 |
| Cephalexin | 21 | $124 | $6 |
| Cyclobenzaprine | 16 | $114 | $7 |
| Lorazepam | 19 | $114 | $6 |
| Glipizide | 20 | $101 | $5 |
2017: 50 drugs
| Sensipar | 67 | $144,043 | $2,150 |
| Renvela | 79 | $108,373 | $1,372 |
| Veltassa | 16 | $23,365 | $1,460 |
| Calcitriol | 438 | $9,605 | $22 |
| Symbicort | 16 | $4,676 | $292 |
| Mycophenolate Mofetil | 16 | $3,814 | $238 |
| Fentanyl | 20 | $3,574 | $179 |
| Nifedipine Er | 51 | $3,054 | $60 |
| Allopurinol | 79 | $2,074 | $26 |
| Metoprolol | 49 | $1,888 | $39 |
| Midodrine | 43 | $1,878 | $44 |
| Atorvastatin | 84 | $1,837 | $22 |
| Furosemide | 285 | $1,620 | $6 |
| Amlodipine Besylate | 198 | $1,616 | $8 |
| Losartan | 129 | $1,589 | $12 |
| Lisinopril | 166 | $1,537 | $9 |
| Clonidine | 156 | $1,483 | $10 |
| Valsartan | 38 | $1,361 | $36 |
| Doxazosin Mesylate | 31 | $1,164 | $38 |
| Potassium Chloride | 25 | $890 | $36 |
| Tamsulosin | 39 | $879 | $23 |
| Hydralazine | 37 | $876 | $24 |
| Levothyroxine | 16 | $652 | $41 |
| Lidocaine-Prilocaine | 13 | $645 | $50 |
| Cartia Xt | 11 | $613 | $56 |
| Omeprazole | 30 | $583 | $19 |
| Benazepril | 51 | $573 | $11 |
| Prednisone | 46 | $492 | $11 |
| Metoprolol | 39 | $458 | $12 |
| Hydrocodone-Acetaminophen | 22 | $455 | $21 |
| Isosorbide Mononitrate Er | 13 | $439 | $34 |
| Simvastatin | 67 | $430 | $6 |
| Atenolol | 39 | $402 | $10 |
| Hydrochlorothiazide | 62 | $396 | $6 |
| Ranitidine | 38 | $374 | $10 |
| Hydrocortisone | 20 | $330 | $17 |
| Glipizide Er | 19 | $295 | $16 |
| Sertraline | 27 | $285 | $11 |
| Zolpidem | 16 | $229 | $14 |
| Gabapentin | 29 | $204 | $7 |
| Megestrol Acetate | 16 | $190 | $12 |
| Carvedilol | 31 | $176 | $6 |
| Spironolactone | 20 | $162 | $8 |
| Lorazepam | 21 | $145 | $7 |
| Tramadol | 21 | $118 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $112 | $10 |
| Mirtazapine | 11 | $104 | $9 |
| Cephalexin | 17 | $99 | $6 |
| Buspirone | 11 | $96 | $9 |
| Glipizide | 15 | $60 | $4 |
2016: 53 drugs
| Renvela | 88 | $128,520 | $1,460 |
| Sensipar | 67 | $113,753 | $1,698 |
| Clinisol | 82 | $9,574 | $117 |
| Calcitriol | 442 | $7,336 | $17 |
| Tacrolimus | 21 | $5,241 | $250 |
| Symbicort | 15 | $4,224 | $282 |
| Colchicine | 13 | $3,343 | $257 |
| Fentanyl | 11 | $2,885 | $262 |
| Tamsulosin | 46 | $2,557 | $56 |
| Nifedipine Er | 48 | $2,304 | $48 |
| Valsartan | 36 | $2,113 | $59 |
| Losartan | 151 | $1,959 | $13 |
| Metoprolol | 47 | $1,940 | $41 |
| Atorvastatin | 69 | $1,813 | $26 |
| Furosemide | 284 | $1,779 | $6 |
| Mycophenolate Mofetil | 20 | $1,690 | $85 |
| Potassium Chloride | 25 | $1,638 | $66 |
| Hydralazine | 56 | $1,572 | $28 |
| Amlodipine Besylate | 197 | $1,565 | $8 |
| Allopurinol | 61 | $1,414 | $23 |
| Midodrine | 34 | $1,309 | $38 |
| Clonidine | 124 | $1,251 | $10 |
| Lisinopril | 133 | $1,251 | $9 |
| Doxazosin Mesylate | 26 | $931 | $36 |
| Lidocaine-Prilocaine | 16 | $750 | $47 |
| Omeprazole | 29 | $733 | $25 |
| Voltaren | 13 | $733 | $56 |
| Zolpidem | 22 | $717 | $33 |
| Hydrocodone-Acetaminophen | 22 | $659 | $30 |
| Benazepril | 63 | $625 | $10 |
| Ranitidine | 50 | $586 | $12 |
| Simvastatin | 67 | $543 | $8 |
| Metoprolol | 47 | $471 | $10 |
| Hydrochlorothiazide | 68 | $432 | $6 |
| Atenolol | 36 | $426 | $12 |
| Azathioprine | 13 | $366 | $28 |
| Prednisone | 33 | $332 | $10 |
| Lorazepam | 19 | $325 | $17 |
| Clopidogrel | 15 | $263 | $18 |
| Megestrol Acetate | 11 | $261 | $24 |
| Amlodipine Besylate-Benazepril | 12 | $196 | $16 |
| Carvedilol | 16 | $182 | $11 |
| Sertraline | 17 | $179 | $11 |
| Triamcinolone Acetonide | 12 | $175 | $15 |
| Pantoprazole | 13 | $164 | $13 |
| Gabapentin | 14 | $131 | $9 |
| Hydrocortisone | 18 | $115 | $6 |
| Mirtazapine | 13 | $104 | $8 |
| Tramadol | 16 | $93 | $6 |
| Ciprofloxacin | 12 | $77 | $6 |
| Paroxetine | 11 | $66 | $6 |
| Cephalexin | 11 | $57 | $5 |
| Glipizide | 11 | $36 | $3 |
2015: 49 drugs
| Renvela | 85 | $126,529 | $1,489 |
| Sensipar | 43 | $48,963 | $1,139 |
| Clinisol | 38 | $4,941 | $130 |
| Calcitriol | 248 | $3,598 | $15 |
| Advair Diskus | 12 | $3,593 | $299 |
| Valsartan | 47 | $3,488 | $74 |
| Tacrolimus | 14 | $3,445 | $246 |
| Symbicort | 12 | $3,110 | $259 |
| Fentanyl | 11 | $2,931 | $266 |
| Nifedipine Er | 44 | $2,573 | $58 |
| Captopril | 11 | $1,686 | $153 |
| Allopurinol | 78 | $1,656 | $21 |
| Hydralazine | 70 | $1,637 | $23 |
| Mycophenolate Mofetil | 18 | $1,623 | $90 |
| Doxazosin Mesylate | 43 | $1,570 | $37 |
| Potassium Chloride | 30 | $1,450 | $48 |
| Amlodipine Besylate | 160 | $1,279 | $8 |
| Clonidine | 126 | $1,235 | $10 |
| Furosemide | 211 | $1,221 | $6 |
| Losartan | 105 | $1,150 | $11 |
| Atorvastatin | 44 | $1,121 | $25 |
| Lisinopril | 102 | $1,067 | $10 |
| Lidocaine-Prilocaine | 11 | $1,054 | $96 |
| Metolazone | 22 | $924 | $42 |
| Zolpidem | 22 | $894 | $41 |
| Atenolol | 33 | $687 | $21 |
| Omeprazole | 38 | $666 | $18 |
| Midodrine | 16 | $654 | $41 |
| Metoprolol | 22 | $632 | $29 |
| Hydrocodone-Acetaminophen | 26 | $598 | $23 |
| Tamsulosin | 30 | $537 | $18 |
| Benazepril | 51 | $506 | $10 |
| Simvastatin | 63 | $497 | $8 |
| Azathioprine | 16 | $477 | $30 |
| Lorazepam | 29 | $387 | $13 |
| Prednisone | 38 | $353 | $9 |
| Metoprolol | 39 | $301 | $8 |
| Gabapentin | 26 | $276 | $11 |
| Megestrol Acetate | 12 | $268 | $22 |
| Hydrochlorothiazide | 45 | $261 | $6 |
| Carvedilol | 25 | $260 | $10 |
| Isosorbide Mononitrate Er | 11 | $247 | $22 |
| Triamcinolone Acetonide | 13 | $218 | $17 |
| Sertraline | 19 | $217 | $11 |
| Hydrocortisone | 22 | $209 | $10 |
| Mirtazapine | 14 | $149 | $11 |
| Tramadol | 12 | $74 | $6 |
| Amiodarone | 12 | $61 | $5 |
| Ciprofloxacin | 12 | $55 | $5 |
2014: 55 drugs
| Renvela | 60 | $72,430 | $1,207 |
| Sensipar | 61 | $55,509 | $910 |
| Sevelamer Carbonate | 11 | $12,720 | $1,156 |
| Diovan | 49 | $11,732 | $239 |
| Januvia | 17 | $7,840 | $461 |
| Fentanyl | 12 | $6,712 | $559 |
| Valsartan | 29 | $5,113 | $176 |
| Calcitriol | 178 | $4,155 | $23 |
| Nifedipine Er | 59 | $3,635 | $62 |
| Advair Diskus | 11 | $3,052 | $277 |
| Colcrys | 18 | $2,517 | $140 |
| Captopril | 18 | $2,507 | $139 |
| Hydralazine | 96 | $2,036 | $21 |
| Calcium Acetate | 23 | $1,847 | $80 |
| Losartan | 101 | $1,387 | $14 |
| Metoprolol | 33 | $1,381 | $42 |
| Lisinopril | 139 | $1,356 | $10 |
| Amlodipine Besylate | 171 | $1,351 | $8 |
| Furosemide | 230 | $1,309 | $6 |
| Clonidine | 121 | $1,261 | $10 |
| Doxazosin Mesylate | 37 | $1,213 | $33 |
| Atorvastatin | 57 | $1,095 | $19 |
| Labetalol | 17 | $1,030 | $61 |
| Allopurinol | 81 | $1,029 | $13 |
| Hydrocodone-Acetaminophen | 32 | $1,003 | $31 |
| Lidocaine-Prilocaine | 22 | $805 | $37 |
| Mycophenolate Mofetil | 12 | $793 | $66 |
| Potassium Chloride | 20 | $789 | $39 |
| Oxybutynin Chloride | 21 | $699 | $33 |
| Tamsulosin | 35 | $671 | $19 |
| Simvastatin | 62 | $629 | $10 |
| Benazepril | 50 | $597 | $12 |
| Midodrine | 18 | $567 | $31 |
| Zolpidem | 59 | $556 | $9 |
| Hydrochlorothiazide | 73 | $554 | $8 |
| Diltiazem 24hr Er | 14 | $540 | $39 |
| Omeprazole | 41 | $510 | $12 |
| Metolazone | 11 | $454 | $41 |
| Gabapentin | 27 | $434 | $16 |
| Atenolol | 33 | $403 | $12 |
| Carvedilol | 38 | $377 | $10 |
| Metoprolol | 37 | $345 | $9 |
| Sertraline | 19 | $316 | $17 |
| Megestrol Acetate | 18 | $300 | $17 |
| Glimepiride | 15 | $273 | $18 |
| Triamterene-Hydrochlorothiazid | 14 | $243 | $17 |
| Tramadol | 31 | $207 | $7 |
| Quetiapine | 11 | $190 | $17 |
| Glipizide | 18 | $158 | $9 |
| Prednisone | 17 | $154 | $9 |
| Lorazepam | 15 | $126 | $8 |
| Diphenoxylate-Atropine | 11 | $101 | $9 |
| Alprazolam | 14 | $80 | $6 |
| Acyclovir | 11 | $79 | $7 |
| Amiodarone | 11 | $71 | $6 |
2013: 53 drugs
| Renvela | 83 | $68,766 | $829 |
| Sensipar | 45 | $45,199 | $1,004 |
| Diovan | 58 | $11,727 | $202 |
| Januvia | 24 | $9,086 | $379 |
| Calcitriol | 166 | $3,989 | $24 |
| Clinisol | 36 | $3,875 | $108 |
| Fentanyl | 14 | $3,811 | $272 |
| Nifedipine Er | 57 | $3,537 | $62 |
| Hydralazine | 92 | $2,942 | $32 |
| Losartan | 91 | $2,827 | $31 |
| Metoprolol | 43 | $2,165 | $50 |
| Atorvastatin | 49 | $1,912 | $39 |
| Clopidogrel | 21 | $1,813 | $86 |
| Amlodipine Besylate | 156 | $1,749 | $11 |
| Furosemide | 253 | $1,708 | $7 |
| Omeprazole | 53 | $1,526 | $29 |
| Potassium Chloride | 39 | $1,460 | $37 |
| Lisinopril | 110 | $1,178 | $11 |
| Diltiazem 24hr Er | 17 | $1,131 | $67 |
| Clonidine | 82 | $1,093 | $13 |
| Calcium Acetate | 11 | $1,076 | $98 |
| Lidocaine-Prilocaine | 20 | $1,026 | $51 |
| Simvastatin | 63 | $950 | $15 |
| Allopurinol | 88 | $852 | $10 |
| Hydrochlorothiazide | 81 | $823 | $10 |
| Labetalol | 17 | $754 | $44 |
| Tamsulosin | 25 | $732 | $29 |
| Amiodarone | 18 | $682 | $38 |
| Doxazosin Mesylate | 20 | $651 | $33 |
| Benazepril | 44 | $604 | $14 |
| Benazepril-Hydrochlorothiazide | 13 | $597 | $46 |
| Megestrol Acetate | 36 | $590 | $16 |
| Sertraline | 33 | $512 | $16 |
| Carvedilol | 27 | $472 | $17 |
| Atenolol | 35 | $461 | $13 |
| Pantoprazole | 12 | $432 | $36 |
| Metoprolol | 39 | $430 | $11 |
| Zolpidem | 52 | $380 | $7 |
| Tramadol | 29 | $332 | $11 |
| Gabapentin | 27 | $326 | $12 |
| Oxybutynin Chloride | 14 | $321 | $23 |
| Quetiapine | 11 | $307 | $28 |
| Terazosin | 13 | $301 | $23 |
| Isosorbide Mononitrate Er | 14 | $298 | $21 |
| Glimepiride | 15 | $270 | $18 |
| Metolazone | 12 | $230 | $19 |
| Hydrocodone-Acetaminophen | 17 | $172 | $10 |
| Acetaminophen-Codeine | 14 | $160 | $11 |
| Metoclopramide | 21 | $157 | $7 |
| Ciprofloxacin | 20 | $122 | $6 |
| Lorazepam | 11 | $110 | $10 |
| Mirtazapine | 11 | $91 | $8 |
| Cephalexin | 11 | $79 | $7 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2022 | 2 | 2 | None | $92 |
| 2020 | 1 | 1 | None | $124 |
| 2019 | 2 | 2 | None | $172 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calliditas Therapeutics US | Tarpeyo | $125 | 1 payment
|
See the published payment
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $125 |
See earlier years (2022, 2020, 2019)
2022: $92
| Amgen | Tavneos | $55 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $37 | 1 payment
|
2020: $124
| AstraZeneca Pharmaceuticals LP | None | $124 | 1 payment
|
2019: $172
| Bard Peripheral Vascular | None | $150 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $22 | 1 payment
|
Professional record
- NPI
- 1902912132
- Licence
- CA A51374California A51374: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-08-21
- NPI last updated
- 2011-12-06
This is when the NPI record was last certified, not a medical board exam.